###begin article-title 0
The E3 Ubiquitin Ligase Triad3A Negatively Regulates the RIG-I/MAVS Signaling Pathway by Targeting TRAF3 for Degradation
###end article-title 0
###begin p 1
Conceived and designed the experiments: PN JH. Performed the experiments: PN TM MS QS. Analyzed the data: PN JH. Contributed reagents/materials/analysis tools: TZ LY THC CFW RL. Wrote the paper: PN JH.
###end p 1
###begin p 2
###xml 589 591 589 591 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">48</sup>
###xml 980 982 980 982 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">48</sup>
###xml 1233 1245 <span type="species:ncbi:11191">Sendai virus</span>
The primary role of the innate immune response is to limit the spread of infectious pathogens, with activation of Toll-like receptor (TLR) and RIG-like receptor (RLR) pathways resulting in a pro-inflammatory response required to combat infection. Limiting the activation of these signaling pathways is likewise essential to prevent tissue injury in the host. Triad3A is an E3 ubiquitin ligase that interacts with several components of TLR signaling and modulates TLR activity. In the present study, we demonstrate that Triad3A negatively regulates the RIG-I RNA sensing pathway through Lys48-linked, ubiquitin-mediated degradation of the tumor necrosis factor receptor-associated factor 3 (TRAF3) adapter. Triad3A was induced following dsRNA exposure or virus infection and decreased TRAF3 levels in a dose-dependent manner; moreover, Triad3A expression blocked IRF-3 activation by Ser-396 phosphorylation and inhibited the expression of type 1 interferon and antiviral genes. Lys48-linked ubiquitination of TRAF3 by Triad3A increased TRAF3 turnover, whereas reduction of Triad3A expression by stable shRNA expression correlated with an increase in TRAF3 protein expression and enhancement of the antiviral response following VSV or Sendai virus infection. Triad3A and TRAF3 physically interacted together, and TRAF3 residues Y440 and Q442-previously shown to be important for association with the MAVS adapter-were also critical for Triad3A. Point mutation of the TRAF-Interacting-Motif (TIM) of Triad3A abrogated its ability to interact with TRAF3 and modulate RIG-I signaling. TRAF3 appears to undergo sequential ubiquitin "immuno-editing" following virus infection that is crucial for regulation of RIG-I-dependent signaling to the antiviral response. Thus, Triad3A represents a versatile E3 ubiquitin ligase that negatively regulates RIG-like receptor signaling by targeting TRAF3 for degradation following RNA virus infection.
###end p 2
###begin title 3
Author Summary
###end title 3
###begin p 4
###xml 894 896 894 896 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">48</sup>
RNA virus infection is detected through TLR-dependent and TLR-independent mechanisms. Early viral replicative intermediates are detected by two recently characterized cystolic viral RNA receptors, RIG-I and MDA-5, leading to the production of pro-inflammatory cytokines and type I interferons (IFNs). Dysfunctional responses, either failure to respond or hyper-responsiveness, may lead to both acute and chronic immunodeficiency and inflammatory diseases. Thus, the intensity and duration of RLR signaling must be tightly controlled. One general mechanism by which innate immune receptors and their downstream adapters are regulated involves protein degradation mediated by the ubiquitination pathway. Our study demonstrates that the E3 ubiquitin ligase Triad3A negatively regulates the RIG-I-like receptor pathway by targeting the adapter molecule TRAF3 for proteasomal degradation through Lys48-linked ubiquitin-mediated degradation. Thus, Triad3A represents a key molecule involved in the negative regulation of the host antiviral response triggered by RNA virus infection.
###end p 4
###begin title 5
Introduction
###end title 5
###begin p 6
###xml 736 739 736 739 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000650-Nakhaei1">[1]</xref>
###xml 740 743 740 743 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000650-Creagh1">[2]</xref>
###xml 744 747 744 747 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000650-Akira1">[3]</xref>
###xml 1213 1216 1213 1216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000650-Hiscott1">[4]</xref>
###xml 1217 1220 1217 1220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000650-Yoneyama1">[5]</xref>
###xml 1221 1224 1221 1224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000650-Yoneyama2">[6]</xref>
###xml 1395 1398 1395 1398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000650-Hiscott1">[4]</xref>
###xml 1734 1737 1734 1737 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000650-Andrejeva1">[7]</xref>
###xml 1738 1741 1738 1741 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000650-Cui1">[8]</xref>
###xml 1742 1745 1742 1745 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000650-Takahasi1">[9]</xref>
Upon recognition of specific molecular components of viruses, the host cell activates multiple signaling cascades that stimulate an innate antiviral response, resulting in the disruption of viral replication, and the mobilization of the adaptive arm of the immune system. Central to the host antiviral response is the production of type 1 interferons (IFNs), a large family of multifunctional immunoregulatory proteins. Multiple Toll like receptor (TLR)-dependent (TLR-3, -4, -7 and 9) and RIG-I-like receptor (RLR) pathways are involved in the cell specific regulation of Type I IFNs, with accumulating evidence that cooperation between different pathways is required to ensure a robust and controlled activation of antiviral response [1],[2],[3]. RIG-I-like receptors (RLRs) - the retinoic acid-inducible gene-I (RIG-I) and melanoma differentiation-associated gene-5 (MDA-5) - are novel cytoplasmic RNA helicases that recognize viral RNA present within the cytoplasm. Although both TLR7 and TLR9 are critical for recognition of viral nucleic acids in the endosomes of plasmacytoid dendritic cells (pDCs), most other cell types recognize viral RNA intermediates through the RLR arm of the innate immune response [4],[5],[6]. Structurally, RIG-I contains two caspase activation and recruitment domains (CARD) at its N-terminus and RNA helicase activity in the C-terminal portion of the molecule [4]. The C-terminal regulatory domain (CTD) (aa 792-925) of RIG-I binds viral RNA in a 5'-triphosphate-dependent manner and activates RIG-I ATPase inducing RNA-dependent dimerization and structural alterations that enable the CARD domain to interact with other downstream adapter protein(s) leading to the transcription of antiviral genes [7],[8],[9].
###end p 6
###begin p 7
###xml 321 325 302 306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000650-Hornung1">[10]</xref>
###xml 326 330 307 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000650-Seth1">[11]</xref>
###xml 331 335 312 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000650-Meylan1">[12]</xref>
###xml 336 340 317 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000650-Xu1">[13]</xref>
###xml 594 597 571 574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000650-Akira1">[3]</xref>
###xml 598 602 575 579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000650-Kawai1">[14]</xref>
###xml 603 607 580 584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000650-Lin1">[15]</xref>
###xml 608 612 585 589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000650-Johnson1">[16]</xref>
RIG-I-dependent signaling to the IKKalpha/beta complex and to TBK1/IKKepsilon is transmitted via a CARD domain containing adapter molecule - alternatively named mitochondrial antiviral signaling (MAVS), interferon-beta stimulator 1 (IPS-1), virus induced signaling adapter (VISA), CARD adapter inducing IFN-beta (CARDIF) [10],[11],[12],[13]. MAVS localizes to the outer mitochondria membrane via a C-terminal mitochondrial transmembrane targeting domain (TM), and its mitochondrial localization acts as a pivotal point for triggering the antiviral cascade via activation of NF-kappaB and IRF-3 [3],[14],[15],[16].
###end p 7
###begin p 8
###xml 138 142 138 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000650-Thompson1">[17]</xref>
###xml 143 147 143 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000650-Meylan2">[18]</xref>
###xml 148 152 148 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000650-Hiscott2">[19]</xref>
###xml 446 450 446 450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000650-Dikic1">[20]</xref>
###xml 455 457 455 457 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">48</sup>
###xml 566 570 566 570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000650-Hunter1">[21]</xref>
###xml 583 585 583 585 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">63</sup>
###xml 702 706 702 706 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000650-Pineda1">[22]</xref>
###xml 707 711 707 711 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000650-Chen1">[23]</xref>
###xml 801 806 801 802 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#954;</italic>
###xml 935 937 931 933 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">63</sup>
###xml 1034 1038 1026 1030 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000650-Johnson1">[16]</xref>
###xml 1039 1043 1031 1035 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000650-Lin2">[24]</xref>
###xml 1044 1048 1036 1040 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000650-Saitoh1">[25]</xref>
###xml 1049 1053 1041 1045 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000650-Wang1">[26]</xref>
###xml 1054 1058 1046 1050 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000650-Zhang1">[27]</xref>
###xml 1211 1215 1203 1207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000650-Kayagaki1">[28]</xref>
###xml 1246 1248 1238 1240 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">63</sup>
###xml 1448 1452 1434 1438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000650-Kayagaki1">[28]</xref>
Activation of TLRs and RLRs results in the dissemination of an antiviral and antimicrobial cascade necessary to combat invading pathogens [17],[18],[19]. Limiting the intensity and duration of TLR and RLR signaling is likewise essential to prevent this protective response from causing inflammatory or autoimmune injury to the host. Ubiquitination is a post-translational modification by which signaling is suppressed in many regulatory pathways [20]. Lys48-linked ubiquitination is one of the most common pathways to target proteins for 26S proteasomal degradation [21], whereas Lys63-linked ubiquitination is involved in protein-protein interactions, recruitment, and assembly of signaling complexes [22],[23]. It has become clear that ubiquitination of signaling adapters is an integral part of NF-kappaB and IFN signaling in response to virus pathogen associated molecular patterns (PAMPs). Deubiquitinating enzymes that remove Lys63-linked ubiquitin are also emerging as key negative regulators of the IFN and NF-kappaB pathways [16],[24],[25],[26],[27]. For example, the deubiquitinating enzyme A (DUBA), a novel OTU-domain DUB negatively regulates IFN signaling following RIG-I, MDA5 or TLR3 stimulation [28]. DUBA specifically removes Lys63-linked ubiquitin chains from TRAF3, resulting in the disruption of interaction between TRAF3 and the downstream kinases IKKepsilon and TBK1 and subsequent blockade of IRF-3 and IRF-7 phosphorylation [28].
###end p 8
###begin p 9
###xml 310 315 310 311 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#954;</italic>
###xml 352 356 348 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000650-Baril1">[29]</xref>
###xml 357 361 353 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000650-Tang1">[30]</xref>
###xml 728 732 724 728 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000650-Hacker1">[31]</xref>
###xml 733 737 729 733 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000650-Oganesyan1">[32]</xref>
###xml 692 698 <span type="species:ncbi:10090">murine</span>
The activation of RIG-I/MDA-5 ultimately leads to the TM-dependent dimerization of the MAVS N-terminal CARD domains, thereby providing an interface for direct binding to and activation of the tumor necrosis factor (TNF) receptor-associated factor (TRAF) family members that are involved in both the IFN and NF-kappaB arms of the innate immune response [29],[30]. TRAF3 is an adapter molecule that is required for the induction of type I IFN and anti-inflammatory cytokine interleukin-10 (IL-10), but is dispensable for expression of pro-inflammatory cytokines in response to viral infection and TLR ligation in bone marrow-derived macrophages (BMMs), plasmacytoid dendritic cells (pDCs), and murine embryonic fibroblasts (MEFs) [31],[32].
###end p 9
###begin p 10
###xml 250 254 246 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000650-Hostager1">[33]</xref>
###xml 495 499 491 495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000650-Ni1">[34]</xref>
###xml 687 691 683 687 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000650-Ni2">[35]</xref>
###xml 692 696 688 692 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000650-Li1">[36]</xref>
###xml 884 888 876 880 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000650-Li2">[37]</xref>
###xml 889 893 881 885 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000650-Wu1">[38]</xref>
###xml 1147 1151 1135 1139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000650-Saha1">[39]</xref>
###xml 1124 1136 <span type="species:ncbi:11191">Sendai virus</span>
TRAF3 was the first TRAF demonstrated to directly associate with CD40. Subsequently, it was shown that TRAF3 negatively regulates CD40 signaling by competing with TRAF2 for CD40 binding, thus impeding CD40-TRAF2 mediated JNK and NF-kappaB activation [33]. Crystal structure of the binding crevice of TRAF3 bound in complex with a 24-residue fragment of the cytoplasmic portion of BAFF receptor (BAFF-R), revealed two amino acids in TRAF3 -Y440A and Q442- that are involved in BAFF-R interaction [34]. Interestingly, other TNFRs such as CD40 contain similar TRAF-interacting motifs (TIMs), defined by the consensus sequence PxQx(T/S), that interact with the same binding crevice on TRAF3 [35],[36]. In addition, the TRAF family member-associated NF-kappaB activator (TANK) adapter and the viral oncogene LMP1 of the Epstein Barr Virus also bind to the same structural crevice of TRAF3 [37],[38]. MAVS regulation of type I IFN induction is achieved by direct and specific interaction with the TIM of TRAF3; interestingly point-mutation of the TIM domain completely abrogates TRAF3-mediated IFN-alpha production in response to Sendai virus infection [39].
###end p 10
###begin p 11
###xml 75 77 75 77 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">48</sup>
###xml 235 239 235 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000650-Chuang1">[40]</xref>
###xml 704 708 697 701 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000650-Fearns1">[41]</xref>
###xml 813 818 806 807 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#954;</italic>
###xml 831 835 820 824 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000650-Fearns1">[41]</xref>
Triad3A is a RING finger type E3 ubiquitin-protein ligase that promotes Lys48-linked ubiquitination and proteolytic degradation of TLR4 and TLR9 and negatively regulates their activation by lipopolysaccharide and CpG-DNA, respectively [40]. Triad3A is the most abundant alternatively spliced form of the Triad family. In addition, Triad3A interacts and promotes down-regulation of two TIR domain containing adapter molecules, TIR-domain-containing adapter-inducing IFN-beta (TRIF) and TRIF-related adapter molecule (TIRAP). Moreover, Triad3A acts as a negative regulator of TNF-alpha signaling by interacting with the TIR homologous (TIRH) domain containing protein receptor-interacting protein 1 (RIP1) [41]. This interaction effectively disrupts RIP1 binding to the TNF-R1 complex and impedes RIP-1-mediated NF-kappaB activation [41].
###end p 11
###begin p 12
###xml 406 408 406 408 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">48</sup>
The identification of a TIM sequence in the N-terminus of Triad3A -using a program written in python language ()- as well as the previously characterized function of Triad3A in TLR signaling, prompted us to investigate the role of Triad3A in the regulation of the RIG-I/MAVS signaling via TRAF3. In the present study, we demonstrate that Triad3A negatively regulates the RIG-I signaling pathway through Lys48-linked ubiquitin-mediated degradation of TRAF3, resulting in the inhibition of the type I IFN response.
###end p 12
###begin title 13
Results
###end title 13
###begin title 14
Triad3A disrupts RIG-I signaling
###end title 14
###begin p 15
###xml 132 136 132 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IFNB</italic>
###xml 323 327 313 317 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IFNB</italic>
###xml 386 390 376 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IFNB</italic>
###xml 440 449 430 439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000650-g001">Figure 1A</xref>
###xml 556 560 536 540 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IFNB</italic>
###xml 585 594 565 574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000650-g001">Figure 1A</xref>
###xml 683 687 659 663 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IFNB</italic>
###xml 753 757 723 727 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IFNB</italic>
###xml 787 796 757 766 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000650-g001">Figure 1A</xref>
###xml 846 851 816 817 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#954;</italic>
###xml 863 872 829 838 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000650-g001">Figure 1B</xref>
###xml 966 971 922 927 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IFNA4</italic>
###xml 1060 1065 1016 1021 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IFNA4</italic>
###xml 1078 1087 1034 1043 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000650-g001">Figure 1C</xref>
###xml 1159 1163 1115 1119 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ISRE</italic>
###xml 1210 1219 1166 1175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000650-g001">Figure 1D</xref>
###xml 1268 1272 1224 1228 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ISRE</italic>
###xml 1423 1427 1371 1375 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ISRE</italic>
###xml 1514 1524 1462 1472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000650.s001">Figure S1A</xref>
###xml 1667 1682 1615 1630 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000650.s001">Figure S1B, S1C</xref>
###xml 1768 1778 1716 1726 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000650.s001">Figure S1D</xref>
###xml 1900 1904 1848 1852 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IFNB</italic>
###xml 1924 1934 1872 1882 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000650.s002">Figure S2A</xref>
###xml 1968 1977 1916 1921 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NF-&#954;B</italic>
###xml 2045 2054 1989 1994 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NF-&#954;B</italic>
###xml 2094 2104 2034 2044 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000650.s002">Figure S2B</xref>
###xml 2213 2218 2153 2154 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#954;</italic>
###xml 1186 1198 <span type="species:ncbi:11191">Sendai virus</span>
The identification of a TIM domain in Triad3A prompted us to examine the ability of Triad3A to inhibit RIG-I mediated activation of IFNB gene transcription; a constitutively active form of RIG-I (aa 1-229, DeltaRIG-I), the MAVS adapter or IKKepsilon, were co-expressed together with Triad3A in 293T cells, together with an IFNB promoter luciferase reporter. A low basal activity of the IFNB promoter was not affected by Triad3A expression (Figure 1A), while co-expression of DeltaRIG-I, MAVS, or IKKepsilon resulted in 196, 132, 61-fold stimulation of the IFNB promoter, respectively (Figure 1A). Co-expression of Triad3A with DeltaRIG-I or MAVS resulted in a complete inhibition of IFNB promoter activity, whereas IKKepsilon mediated activation of the IFNB promoter remained unchanged (Figure 1A). Similar results were also obtained with the NF-kappaB response (Figure 1B); expression of DeltaRIG-I, MAVS or IKKepsilon, (co-expressed together with IRF-7) activated IFNA4 promoter activity 34, 18, 49-fold, respectively, while co-expression of Triad3A blocked IFNA4 activation (Figure 1C). Furthermore, Triad3A blocked interferon stimulated response element (ISRE) activation following Sendai virus infection (Figure 1D). A dose-response curve was performed using the ISRE promoter with increasing amounts of Triad3A and DeltaRIG-I, MAVS, TRIF, or TBK1 expression plasmids; DeltaRIG-I resulted in 893-fold induction of the ISRE promoter, and Triad3A co-expression diminished activation in a dose dependent manner (Figure S1A). Similarly, MAVS or TRIF adapters activated the ISRE by 785- and 863-fold, respectively; Triad3A again dramatically reduced ISRE activation (Figure S1B, S1C). In contrast, Triad3A did not significantly decrease TBK1-mediated ISRE activation (Figure S1D). Triad3A co-expression with MDA5 or an active form of TLR3 fused to CD4 (CD4-TLR3) resulted in a complete inhibition of IFNB promoter activity (Figure S2A). Triad3A inhibited MDA5-induced NF-kappaB promoter activity; however Triad3A inhibition of CD4-TLR3 mediated NF-kappaB promoter activity was less pronounced (Figure S2B). These experiments suggested that Triad3A was a strong inhibitor of RIG-I signaling to IRF-3, IRF-7 and NF-kappaB and suggested that Triad3A may target an adapter molecule common to both the TLR and RLR signaling pathways.
###end p 15
###begin title 16
Triad3A inhibits RIG-I/MAVS-mediated transactivation of type 1 IFN promoters.
###end title 16
###begin p 17
###xml 63 67 63 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IFNB</italic>
###xml 79 88 79 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NF-&#954;B</italic>
###xml 94 99 90 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IFNA4</italic>
###xml 342 347 328 333 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IFNA4</italic>
###xml 561 573 <span type="species:ncbi:11191">Sendai virus</span>
293T cells were transfected with pRLTK control plasmid and (A) IFNB-pGL3, (B), NF-kappaB, (C) IFNA4-pGL3 reporter plasmids, the pcDNA3 vector or expression plasmids encoding DeltaRIG-I, MAVS, IKKepsilon, as well as Triad3A expression plasmid as indicated. In addition,100 ng of IRF-7 plasmid was added per well for the transactivation of the IFNA4 promoter. (D) 293T cells were transfected with pcDNA3 or Triad3A expression vector, along with pRLTK control plasmid (100 ng) and ISRE-Luc reporter plasmid (200 ng). 24h post-transfection cells were infected with Sendai virus for 16h. Luciferase activity was analyzed at 24h post-transfection by the Dual-Luciferase Reporter assay as described by the manufacturer (Promega). Relative luciferase activity was measured as fold activation (relative to the basal level of reporter gene in the presence of pcDNA3 vector after normalization with co-transfected RLU activity); values are mean +/- S.D. for three experiments.
###end p 17
###begin title 18
Triad3A inhibits downstream IFN activation
###end title 18
###begin p 19
###xml 196 200 196 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000650-Paz1">[42]</xref>
###xml 266 274 262 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000650-g002">Figure 2</xref>
###xml 276 282 272 278 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lane 3</italic>
###xml 358 366 354 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000650-g002">Figure 2</xref>
###xml 368 374 364 370 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lane 4</italic>
###xml 441 449 437 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000650-g002">Figure 2</xref>
###xml 451 460 447 456 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lanes 3&#8211;5</italic>
###xml 494 502 490 498 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000650-g002">Figure 2</xref>
###xml 504 513 500 509 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lanes 4&#8211;6</italic>
###xml 633 641 629 637 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000650-g002">Figure 2</xref>
###xml 643 652 639 648 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lanes 7&#8211;8</italic>
###xml 782 790 774 782 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000650-g002">Figure 2</xref>
###xml 792 801 784 793 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lanes 4&#8211;6</italic>
###xml 859 867 851 859 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000650-g002">Figure 2</xref>
###xml 869 878 861 870 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lanes 7&#8211;8</italic>
As a measure of activation of the IFN signaling pathway, the phosphorylation state of IRF-3 was evaluated by immunoblot in the presence of Triad3A using the phosphospecific Ser-396 IRF-3 antibody [42]. DeltaRIG-I co-expression induced Ser-396 IRF-3 phosphorylation (Figure 2, lane 3), while co-expression of Triad3A completely blocked IRF-3 phosphorylation (Figure 2, lane 4). MAVS expression likewise induced Ser-396 IRF-3 phosphorylation (Figure 2, lanes 3-5); that was abrogated by Triad3A (Figure 2, lanes 4-6). In contrast, TBK1 co-expression in the presence or absence of Triad3A did not alter the IRF-3 phosphorylation state (Figure 2, lanes 7-8). Complementing the phosphorylation status, Triad3A also inhibited DeltaRIG-I and MAVS-induced dimerization of endogenous IRF-3 (Figure 2, lanes 4-6), but did not affect TBK1-induced IRF-3 dimer formation (Figure 2, lanes 7-8), indicating that Triad3A targets RLR signaling upstream of TBK1.
###end p 19
###begin title 20
Triad3A inhibits DeltaRIG-I and MAVS-mediated activation of IRF-3.
###end title 20
###begin p 21
293T cells were cotransfected with 500 ng of IRF-3, 1 microg myc-DeltaRIG-I, myc-MAVS, or GFP-TBK1 and 2 microg of Flag-Triad3A expression construct as indicated. Whole cell extracts (40 microg) were resolved by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and analyzed by immunoblotting for IRF-3 pSer396, Flag-Triad3A, myc-DeltaRIG-I, myc-MAVS, GFP-TBK1, and beta-Actin. For IRF-3 dimerization assay, 293T cells were transfected with 1 microg of pcDNA3-, DeltaRIG-I-, MAVS-, or TBK1-expressing plasmid together with 2 microg of pcDNA3 or Triad3A-expressing plasmid as indicated above the lanes. Whole cell extracts (40 microg) were subjected to SDS-PAGE or native PAGE and probed with anti-IRF-3 Ser-396 phosphospecific antibody to detect IRF-3 phosphorylation or anti-IRF-3 antibody to detect IRF-3 dimerization.
###end p 21
###begin title 22
Triad3A is induced by RNA virus infection and regulates TRAF3 levels
###end title 22
###begin p 23
###xml 143 147 139 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000650-Arimoto1">[43]</xref>
###xml 389 398 385 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000650-g003">Figure 3A</xref>
###xml 644 653 633 642 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000650.s003">Figure S3</xref>
###xml 751 760 740 749 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000650-g003">Figure 3B</xref>
###xml 938 947 927 936 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000650-g003">Figure 3C</xref>
###xml 191 196 <span type="species:ncbi:9606">human</span>
###xml 263 289 <span type="species:ncbi:11276">vesicular stomatitis virus</span>
###xml 291 294 <span type="species:ncbi:11276">VSV</span>
###xml 300 312 <span type="species:ncbi:11191">Sendai virus</span>
###xml 314 317 <span type="species:ncbi:11191">SeV</span>
###xml 777 780 <span type="species:ncbi:11191">SeV</span>
Previous studies demonstrated that the E3 ligase RNF125-a negative regulator of RIG-I- was induced following IFN-alpha and poly(I:C) treatment [43]. Endogenous Triad3A protein was induced in human bronchial epithelial A549 cells following dsRNA treatment for 6h, vesicular stomatitis virus (VSV), or Sendai virus (SeV) infection for 16h; correlating with the degradation of TRAF3 protein (Figure 3A). Moreover, Triad3A protein expression is induced following IFN-alpha/beta treatment (data not shown). In addition, it was determined by time-course analysis that 6h dsRNA treatment and 16h virus infection resulted in maximal TRAF3 degradation (Figure S3). Expression of increasing amounts of Triad3A decreased TRAF3 levels in a dose-dependent manner (Figure 3B). Additionally, SeV-mediated degradation of TRAF3 in A549 cells was blocked by the proteasome inhibitors lactacystin and Mg132, but not by the lysosomal protease inhibitor E64 (Figure 3C).
###end p 23
###begin title 24
Triad3A is induced by RNA virus infection and regulates TRAF3 levels.
###end title 24
###begin p 25
###xml 77 80 <span type="species:ncbi:11276">VSV</span>
###xml 749 761 <span type="species:ncbi:11191">Sendai virus</span>
(A) A549 cells were treated with 20 microg/ml dsRNA for 6h, or infected with VSV at a MOI 1 or infected with Sendai Virus for 16h. Whole cell extract (40 microg) was resolved by SDS-7.5% PAGE and transferred to nitrocellulose and probed with anti-Triad3A, anti-TRAF3, anti-ISG56, anti-RIG-I and anti-beta-Actin antibodies. (B) 293T cells were co-transfected with expression vectors for myc-tagged TRAF3 and increasing amount of expression vector for Flag-tagged Triad3A as indicated. The cells were subsequently lysed, and cell lysates were resolved by SDS-PAGE. The expression levels of TRAF3, Triad3A, and beta-Actin were analyzed by immunoblotting with antibodies against myc, Flag, or beta-Actin, respectively. (C) A549 cells were infected with Sendai virus 40 HAU/ml and treated with either 5microM of lactacystin or 10microM of Mg132 or 5microM of E64. Whole cell extracts were resolved by SDS-7.5% PAGE and transferred to nitrocellulose and probed with anti-TRAF3, and anti-beta-Actin antibodies.
###end p 25
###begin title 26
Stable knock-down of Triad3A correlates with increased TRAF3 protein levels and ISG expression following virus infection
###end title 26
###begin p 27
###xml 341 350 341 350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000650-g004">Figure 4A</xref>
###xml 409 413 409 413 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ISRE</italic>
###xml 549 558 549 558 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000650-g004">Figure 4B</xref>
###xml 561 565 561 565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000650-Arimoto1">[43]</xref>
###xml 882 890 882 887 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IFN-&#946;</italic>
###xml 895 905 892 898 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IFN-&#945;2</italic>
###xml 975 984 968 977 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000650-g004">Figure 4C</xref>
###xml 998 1009 991 1002 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IP-10 ISG56</italic>
###xml 1011 1015 1004 1008 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IS15</italic>
###xml 1065 1074 1058 1067 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000650-g004">Figure 4C</xref>
###xml 1083 1088 1076 1081 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1</italic>
###xml 1126 1135 1119 1128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000650-g004">Figure 4C</xref>
###xml 1273 1282 1259 1268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000650-g004">Figure 4D</xref>
###xml 1552 1561 1538 1547 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000650-g004">Figure 4E</xref>
###xml 1739 1748 1725 1734 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000650-g004">Figure 4E</xref>
###xml 1826 1831 1812 1813 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#954;</italic>
###xml 498 501 <span type="species:ncbi:11191">SeV</span>
###xml 769 772 <span type="species:ncbi:11191">SeV</span>
###xml 1258 1261 <span type="species:ncbi:11191">SeV</span>
###xml 1297 1300 <span type="species:ncbi:11276">VSV</span>
###xml 1322 1325 <span type="species:ncbi:11276">VSV</span>
###xml 1459 1462 <span type="species:ncbi:11276">VSV</span>
To further confirm the involvement of Triad3A in regulating TRAF3 turnover, two shRNA expression vectors - shRNA1 and shRNA2 that target Triad3A nucleotide sequences 1,532-1,551 and 1,195-1,214, respectively - were used to stably knock-down Triad3A in A549 cells. Knock-down of Triad3A resulted in a 5-fold increase in TRAF3 protein levels (Figure 4A). Interference with endogenous Triad3A also modulated the ISRE promoter; ISRE activity was 3-fold higher in Triad3A knock-down cells infected with SeV, compared to cells expressing scrambled shRNA (Figure 4B). [43]. To investigate the physiological effects of Triad3A inhibition on downstream IFN-stimulated target genes, expression of multiple ISGs were examined by quantitative PCR in A549-Triad3A knock-down cells. SeV infection (40 hemagglutination units/ml (HAU)) in Triad3A knockdown cells were led to a 3-4 fold increase in IFN-beta and IFN-alpha2 mRNA expression 12h post-infection (p.i.) compared to control cells (Figure 4C). Similarly, IP-10 ISG56, IS15 transcripts were increased 3-4 fold at 12h p.i. (Figure 4C), while STAT1 levels remained relatively constant (Figure 4C). In addition, levels of IFN-alpha and IFN-beta released in the supernatant monitored by ELISA increased 2-fold following SeV infection (Figure 4D). Finally, in VSV infected A549 cells, VSV proteins (nucleocapsid (N), surface glycoprotein (G), and matrix (M)) were detected at 8h p.i., whereas in Triad3A knock-down cells, VSV protein expression was delayed, with viral proteins detected only at 16h post-infection (Figure 4E). Notably, in A549 control cells TRAF3 protein levels decreased over time following virus infection, whereas in Triad3A knock-down cells TRAF3 protein levels remained constant (Figure 4E). These results indicate the involvement of Triad3A in regulating IFN and NF-kappaB dependent gene expression following RNA virus infection.
###end p 27
###begin title 28
Stable knock-down of Triad3A increases TRAF3 protein levels and ISG expression following virus infection.
###end title 28
###begin p 29
###xml 319 323 316 320 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ISRE</italic>
###xml 1051 1055 1046 1050 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IFNB</italic>
###xml 1057 1061 1052 1056 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IFNA</italic>
###xml 1063 1069 1058 1064 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CXCL10</italic>
###xml 1071 1076 1066 1071 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ISG56</italic>
###xml 1078 1083 1073 1078 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ISG15</italic>
###xml 1089 1094 1084 1089 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1</italic>
###xml 1214 1221 1209 1216 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B-Actin</italic>
###xml 1320 1325 1315 1320 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAPDH</italic>
###xml 417 429 <span type="species:ncbi:11191">Sendai virus</span>
###xml 883 895 <span type="species:ncbi:11191">Sendai virus</span>
###xml 1476 1488 <span type="species:ncbi:11191">Sendai virus</span>
###xml 1667 1670 <span type="species:ncbi:11276">VSV</span>
###xml 1817 1820 <span type="species:ncbi:11276">VSV</span>
(A) Whole cell extracts from A549 stable shRNA Triad3A and shRNA control cells was resolved by SDS-7.5% PAGE, transferred to nitrocellulose and probed with anti-Triad3A, anti-TRAF3, and anti-beta-Actin antibodies. (B) Stable shRNA Triad3A and control A549 cells were transfected with pRLTK control plasmid (100 ng) and ISRE-Luc reporter plasmid (200 ng). Approximately 24h after transfection cells were infected with Sendai virus for 16h as indicated. Luciferase activity was analyzed by the Dual-Luciferase Reporter assay as described by the manufacturer (Promega). Relative luciferase activity was measured as fold activation (relative to the basal level of reporter gene in the presence of pcDNA3 vector after normalization with co-transfected RLU activity); values are mean +/- S.D. for three experiments. (C) A549 stable shRNA Triad3A and shRNA control cells were infected with Sendai virus at 40 HAU/ml from 0 to 12h p.i. DNase-treated total RNA were prepared at the indicated times and subjected to real-time PCR analysis for quantification of IFNB, IFNA, CXCL10, ISG56, ISG15, and STAT1. Results are presented as a relative quantification based on the relative expression levels of target gene mRNA versus B-Actin mRNA, as a reference gene (values of ratios are indicated on the bar graphs). Normalization using GAPDH mRNA levels as reference gave similar results (data not shown). (D) Supernatants from A549 stable shRNA Triad3A and shRNA control cells infected with Sendai virus at 40 HAU/ml were collected 14h post-infection and ELISA assay was performed for IFN-beta and IFN-alpha. (E) A549 stable shRNA Triad3A and shRNA control cells were infected with VSV at a MOI 1 from 0 to 16h p.i. Whole cell extract (40 microg) was resolved by SDS-7.5% PAGE and transferred to nitrocellulose and probed with anti-VSV and anti-TRAF3.
###end p 29
###begin title 30
TIM domain of Triad3A interacts with the TRAF domain of TRAF3
###end title 30
###begin p 31
###xml 312 321 312 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000650-g005">Figure 5A</xref>
###xml 576 585 576 585 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000650-g005">Figure 5A</xref>
###xml 970 979 970 979 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000650-g005">Figure 5B</xref>
###xml 981 987 981 987 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lane 4</italic>
###xml 1204 1213 1204 1213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000650-g005">Figure 5B</xref>
###xml 1215 1221 1215 1221 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lane 5</italic>
###xml 1332 1341 1332 1341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000650-g005">Figure 5C</xref>
###xml 1343 1349 1343 1349 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lane 6</italic>
###xml 1428 1437 1428 1437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000650.s004">Figure S4</xref>
###xml 1525 1534 1521 1526 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NF-&#954;B</italic>
###xml 1539 1546 1531 1535 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IFN&#946;</italic>
###xml 1614 1625 1603 1614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000650-g005">Figure 5D,E</xref>
The functional specificity of TRAFs is dictated by their ability to recognize and bind distinct structural motifs, termed the TRAF-interacting motif (TIM), with the consensus sequence PxQx(T/S). This motif contacts TRAF proteins within a structurally conserved binding crevice within the C-terminal TRAF domain (Figure 5A). Using multiple sequence alignment, we identified an N-terminal motif in Triad3A - amino acid residues 316 -PMQES- 320 - with substantial homology to the consensus TIM that is also found on the adapter molecule MAVS - amino acid residues 143-PVQDT-147 (Figure 5A). Previously, it has been reported that the TIM domain of MAVS interacts with amino acid residues Y440 and Q442 within the TRAF domain of TRAF3. As a result, co-immunoprecipitation experiments were performed to detect an association of Triad3A and TRAF3; following immunoprecipitation of Flag-tagged TRAF3, immunoblot analysis revealed that TRAF3 and Triad3A co-precipitate together (Figure 5B, lane 4). Co-immunoprecipitation of TRAF3 (Y440A/Q442A) and Triad3A revealed that this interaction was impaired, demonstrating that the hydrophobic residues in the TRAF3 binding crevice are important for binding to Triad3A (Figure 5B, lane 5). In the reciprocal experiment, Triad3A S320D was unable to bind TRAF3 in co-immunoprecipitation experiments (Figure 5C, lane 6) and increasing amounts of Triad3A S320D failed to promote TRAF3 degradation (Figure S4). Furthermore, Triad3A S320D no longer inhibited DeltaRIG-I-mediated activation of the NF-kappaB and IFNbeta gene transcription but readily inhibited TRIF-mediated activation (Figure 5D,E), thus indicating the specificity of the TIM domain of Triad3A for TRAF3.
###end p 31
###begin title 32
The TIM domain of Triad3A interacts with the TRAF domain.
###end title 32
###begin p 33
###xml 1387 1391 1379 1383 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IFNB</italic>
###xml 1402 1407 1394 1399 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NF-kB</italic>
(A) Schematic representation of TRAF3, Triad3A, and MAVS. TRAF3 contains a N-terminus RING domain and a C-terminus TRAF domain where a hydrophobic binding cleft (Y440/Q442) is located. Triad3A contains a TRIAD domain consisting of two RING domains and an 'in-between-RING' (IBR) domain. The N-terminus of Triad3A contains a motif (316 -PMQES-320) that matches the consensus TRAF-intercating-motif (TIM), PxQx(T/S). MAVS adapter is composed of a N-terminus CARD domain, as well as a TIM (143-PVQDT-147) located in the proline-rich region. In addition, the C-terminus of MAVS is composed of a Transmembrane (TM) domain for anchoring to the outer-mitochondrial membrane. (B) 293T cells were transfected with myc-tagged Triad3A with Flag-tagged TRAF3 or Flag-TRAF3 Y440A/Q442A as indicated, in the presence of 5microM of Lactacystin at 6h post-transfection. Whole cell extracts were immunoprecipitated with anti-Flag Ab, and then analyzed with anti-myc Ab. (C) 293T cells were transfected with myc-tagged TRAF3 with Flag-tagged Triad3A or Flag-Triad3A S320D as indicated, in the presence of 5microM of Lactacystin at 6h post-transfection. Whole cell extracts were immunoprecipitated with an anti-myc Ab, and then analyzed by with anti-Flag Ab. Cell lysates were analyzed by immunoblotting with anti-myc and anti-Flag antibodies. (D,E) 293T cells were transfected with pRLTK control plasmid, IFNB-pGL3 (D), NF-kB (E) reporter plasmid and the pcDNA3 vector or expression plasmids encoding DeltaRIG-I, TRIF as well as Triad3A or Triad3A S320D expression plasmid as indicated. Luciferase activity was analyzed at 24h post-transfection by the Dual-Luciferase Reporter assay as described by the manufacturer (Promega). Relative luciferase activity was measured as fold activation (relative to the basal level of reporter gene in the presence of pcDNA3 vector after normalization with co-transfected RLU activity); values are mean +/- S.D. for three experiments.
###end p 33
###begin title 34
Triad3A mediates Lys 48-linked ubiquitination of TRAF3
###end title 34
###begin p 35
###xml 73 75 73 75 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">48</sup>
###xml 102 109 102 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 196 198 196 198 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">48</sup>
###xml 206 208 206 208 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">63</sup>
###xml 223 232 223 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000650-g006">Figure 6A</xref>
###xml 455 464 455 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000650-g006">Figure 6B</xref>
###xml 466 472 466 472 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lane 8</italic>
###xml 548 557 548 557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000650-g006">Figure 6B</xref>
###xml 559 566 559 566 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lane 10</italic>
###xml 608 617 608 617 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000650-g006">Figure 6B</xref>
###xml 619 625 619 625 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lane 7</italic>
###xml 687 696 687 696 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000650-g006">Figure 6B</xref>
###xml 698 704 698 704 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lane 9</italic>
###xml 740 742 740 742 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">48</sup>
###xml 779 788 779 788 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000650-g006">Figure 6B</xref>
###xml 790 797 790 797 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lane 13</italic>
###xml 810 812 810 812 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">63</sup>
###xml 840 849 840 849 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000650-g006">Figure 6B</xref>
###xml 851 858 851 858 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lane 14</italic>
###xml 928 937 928 937 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000650-g006">Figure 6C</xref>
###xml 939 945 939 945 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lane 2</italic>
###xml 1035 1044 1035 1044 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000650-g006">Figure 6C</xref>
###xml 1046 1054 1046 1054 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lane 3,5</italic>
To test whether Triad3A-mediated degradation of TRAF3 was promoted by Lys48-linked ubiquitination, an in vivo ubiquitination assay was performed with Flag-tagged TRAF3, HA-tagged wild type or (Lys48 and Lys63) Ub products (Figure 6A), and sub-optimal levels of myc-tagged Triad3A and Triad3A S320D to limit TRAF3 degradation. Following immunoprecipitation of Flag-tagged TRAF3, immunoblot analysis revealed that Triad3A mediated TRAF3 polyubiquitination (Figure 6B, lane 8), with polyubiquitination increasing in the presence of Triad3A and Mg132 (Figure 6B, lane 10), compared to TRAF3 and ubiquitin alone (Figure 6B, lane 7). In contrast, Triad3A S320D did not polyubiquitinate TRAF3 (Figure 6B, lane 9); furthermore, Triad3A promoted Lys48-linked polyubiquitination of TRAF3 (Figure 6B, lane 13) but not Lys63-linked polyubiquitination (Figure 6B, lane 14). Cells expressing optimal levels of Triad3A readily degraded TRAF3 (Figure 6C, lane 2), whereas Triad3A was unable to degrade TRAF3 in the presence of K48R and KO Ub mutants (Figure 6C, lane 3,5).
###end p 35
###begin title 36
###xml 20 22 20 22 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">48</sup>
Triad3A promotes Lys48-linked polyubiquitination of TRAF3.
###end title 36
###begin p 37
(A) Schematic illustration of HA- wild type and ubiquitin mutants. (B) 293T cells were transfected with expression vectors for Flag-tagged TRAF3, myc-tagged Triad3A, myc-tagged Triad3AS320D, and wild type or HA-tagged ubiquitin mutants and were treated with 10 microM of Mg132 at 6h post-transfection where indicated. Cell lysates were immunoprecipitated with anti-Flag, and immunoblotted with anti-HA. (C) 293T cells were transfected with Flag-tagged Triad3A, myc-tagged TRAF3, and HA-tagged ubiquitin mutants as indicated.
###end p 37
###begin title 38
TRAF3 undergoes biphasic polyubiquitination and dissociates from MAVS following virus infection
###end title 38
###begin p 39
###xml 442 451 442 451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000650-g007">Figure 7A</xref>
###xml 489 496 489 496 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 619 621 619 621 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">48</sup>
###xml 629 631 629 631 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">63</sup>
###xml 655 659 655 659 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000650-Newton1">[44]</xref>
###xml 670 672 670 672 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">63</sup>
###xml 731 740 731 740 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000650-g007">Figure 7B</xref>
###xml 767 769 767 769 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">48</sup>
###xml 839 848 839 848 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000650-g007">Figure 7B</xref>
###xml 1029 1037 1029 1037 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000650-g008">Figure 8</xref>
###xml 139 142 <span type="species:ncbi:11191">SeV</span>
As both MAVS and Triad3A contain well-characterized TIM domains, the interaction between endogenous TRAF3 and Triad3A was next examined in SeV-infected A549 cells. Following co-immunoprecipitation with anti-TRAF3 antibody, a MAVS-TRAF3 complex was detected at 8h p.i., whereas at 16h, Triad3A disrupted this interaction by associating directly with TRAF3, suggesting that both Triad3A and MAVS compete for the same binding residues on TRAF3 (Figure 7A). Importantly, a kinetic analysis of in vivo TRAF3 ubiquitination demonstrated that endogenous TRAF3 was subject to differential biphasic polyubiquitination; using Lys48 and Lys63 specific Ub antibodies [44], early Lys63-linked polyubiquitination was detected at 4h and 8h p.i. (Figure 7B), whereas a late phase Lys48-linked polyubiquitination of TRAF3 was detected at 12h and 16h p.i. (Figure 7B). Thus, TRAF3- mediated antiviral signaling appears to be regulated by recruitment of TRAF3 to the MAVS TIM, followed by Triad3A competition for the same binding crevice of TRAF3 (Figure 8).
###end p 39
###begin title 40
TRAF3 undergoes biphasic polyubiquitination and dissociates from MAVS following virus infection.
###end title 40
###begin p 41
###xml 438 440 430 432 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">48</sup>
###xml 448 450 440 442 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">63</sup>
###xml 34 46 <span type="species:ncbi:11191">Sendai virus</span>
###xml 253 265 <span type="species:ncbi:11191">Sendai virus</span>
(A) A549 cells were infected with Sendai virus 40 HAU/ml in the presence of 5microM of Lactacystin, immunoprecipitated with an anti-TRAF3 antibody and then analyzed by immunoblotting with anti-Triad3A and anti-MAVS Ab. (B) A549 cells were infected with Sendai virus 40 HAU/ml in the presence of 5microM of Lactacystin and samples were collected every 4h p.i. Cell lysates were immunoprecipitated with ant-TRAF3, and immunoblotted with Lys48 and Lys63 anti-ubiquitin specific antibodies.
###end p 41
###begin title 42
Model of TRAF3 dependent regulation of RIG-I signaling via sequential ubiquitination.
###end title 42
###begin p 43
###xml 136 138 136 138 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">63</sup>
###xml 284 286 278 280 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">63</sup>
###xml 475 477 469 471 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">48</sup>
At early times after RNA virus infection (4-8h), MAVS interacts with TRAF3 via its TRAF interacting motif (TIM); TRAF3 is subject to Lys63 polyubiquitination, leading to recruitment of the downstream kinases TBK1/IKKepsilon and production of type I IFN. Subsequently, DUBA removes Lys63 polyubiquitination from TRAF3 which dissociates the TRAF3-TBK1 signaling complex. At late times after infection (12-16h), Triad3A physically associates TRAF3 via its TIM which promotes Lys48 polyubiquitination of TRAF3, and subsequent proteasomal degradation.
###end p 43
###begin title 44
Discussion
###end title 44
###begin p 45
###xml 184 186 180 182 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">48</sup>
###xml 603 605 595 597 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">48</sup>
###xml 1045 1047 1037 1039 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">63</sup>
###xml 1179 1183 1165 1169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000650-Kayagaki1">[28]</xref>
###xml 1205 1207 1191 1193 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">48</sup>
###xml 1321 1329 1307 1315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000650-g008">Figure 8</xref>
###xml 580 583 <span type="species:ncbi:11276">VSV</span>
The present study demonstrates that the E3 ubiquitin ligase Triad3A blocks RIG-I-mediated signaling to NF-kappaB and IRF pathways by targeting the TRAF3 adapter for degradation via Lys48-linked ubiquitinination. Several observations support this conclusion: 1) co-expression of Triad3A blocked DeltaRIG-I dependent IRF-3 phosphorylation and dimerization; 2) Triad3A expression decreased TRAF3 protein levels in a dose-dependent manner; 3) knock-down of Triad3A by shRNA increased endogenous TRAF3 protein levels, increased ISG mRNA levels following virus infection, and inhibited VSV replication; 4) Lys48-linked ubiquitination of TRAF3 by Triad3A increased TRAF3 turnover; and 5) Triad3A and TRAF3 physically interacted together, an interaction that was impaired by mutation of TRAF3 (Y440A/Q442A), or reciprocally by point mutation of the TIM domain in Triad3A (S320D). TRAF3 appears to undergo a biphasic ubiquitination following virus infection that is crucial for regulation of RIG-I dependent signaling to the antiviral response. Early Lys63-linked polyubiquitination of TRAF3 leads to the recruitment of TBK1/IKKepsilon and subsequent activation of the antiviral response [28], while late phase Lys48-linked polyubiquitination by Triad3A ultimately degrades TRAF3 and leads to shut-down of the antiviral response (Figure 8).
###end p 45
###begin p 46
###xml 227 229 227 229 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">48</sup>
###xml 244 246 244 246 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">63</sup>
###xml 269 273 269 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000650-Arimoto1">[43]</xref>
###xml 274 278 274 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000650-Gack1">[45]</xref>
###xml 338 340 334 336 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">63</sup>
###xml 452 456 448 452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000650-Gack1">[45]</xref>
###xml 482 484 478 480 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">48</sup>
###xml 559 563 555 559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000650-Arimoto1">[43]</xref>
###xml 700 704 696 700 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000650-Arimoto1">[43]</xref>
Recent studies have highlighted the importance of ubiquitination in modulating the innate immune response to invading pathogens via both the TLR and RLR pathways. For example, the RIG-I cytoplasmic RNA sensor undergoes both Lys48-linked and Lys63-linked ubiquitination [43],[45]: the second CARD domain undergoes TRIM25alpha-mediated, Lys63-linked ubiquitination at Lys-172, resulting in RIG-I/MAVS association and triggering of the antiviral response [45]; RIG-I also undergoes Lys48-linked ubiquitination, leading to RIG-I proteasomal degradation by RNF125 [43]. Additionally, RNF125 conjugates ubiquitin to MDA5 and MAVS, thus inhibiting the assembly of the downstream antiviral signaling complex [43]. Overall, multiple steps in the RLR pathway are regulated by ubiquitination to ensure a properly modulated antiviral cascade.
###end p 46
###begin p 47
###xml 208 210 204 206 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">48</sup>
###xml 313 317 309 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000650-Chuang1">[40]</xref>
###xml 318 322 314 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000650-Fearns1">[41]</xref>
###xml 460 464 452 456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000650-Chuang1">[40]</xref>
###xml 465 469 457 461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000650-Fearns1">[41]</xref>
###xml 800 804 792 796 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000650-Chuang1">[40]</xref>
In addition to the newly described role of Triad3A in the regulation of the RIG-I response, previous studies demonstrated that Triad3A negatively regulates both the TLR and TNF-alpha pathways by promoting Lys48-linked, ubiquitin-mediated degradation of TLR4, TLR9 and TIR domain-containing adapters TRIF and TRAM [40],[41]. Triad3A regulation of the TNF-alpha pathway is achieved via a proteolysis-independent mechanism that impedes RIP1 binding to the TNF-R1 [40],[41]. Furthermore, Triad3A promotes ubiquitination and proteasomal degradation of RIP1 following disruption of the RIP-1-Hsp90 complex. Both Hsp90 and Triad3A form a complex that co-ordinates the homeostasis of RIP1; treatment of cells with geldanamycin to disrupt the Hsp90 complex leads to proteasomal degradation of RIP1 by Triad3A [40]. The present study further illustrates the versatility of Triad3A as a negative regulator of innate signaling pathways.
###end p 47
###begin p 48
###xml 224 228 224 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000650-Cheng1">[46]</xref>
###xml 229 233 229 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000650-Hu1">[47]</xref>
###xml 461 465 455 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000650-Oganesyan1">[32]</xref>
###xml 466 470 460 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000650-Saha1">[39]</xref>
###xml 613 626 607 620 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000650.s002">Figure S2A, B</xref>
Both TLR and RLR pathways converge upon TRAF3 in the activation of the antiviral cascade. TRAF3 was originally described as a cytoplasmic adapter that interacted with CD40 and LMP1 and modulated the adaptive immune response [46],[47]. The generation of TRAF3 -/- bone marrow-derived macrophages established TRAF3 as a key molecule in signaling to the production of type I IFNs that functioned as a bridge between MAVS and the downstream kinases TBK1/IKKepsilon [32],[39]. Triad3A mediated degradation of TRAF3 results not only in the inhibition of RIG-I signaling, but also inhibition of MDA5 and TLR3 signaling (Figure S2A, B).
###end p 48
###begin p 49
###xml 153 157 153 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000650-Saha1">[39]</xref>
###xml 406 410 406 410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000650-Li1">[36]</xref>
###xml 537 546 537 546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000650-g006">Figure 6B</xref>
###xml 619 628 619 628 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000650-g007">Figure 7A</xref>
The TIM sequence of MAVS (aa 143-PVQDT-147) binds to the hydrophobic C-terminal crevice of TRAF3 (TRAF domain) located between amino acids Y440 and Q442 [39]. The TIM motif represents a binding interface that recognizes different TRAFs with varying degrees of specificity. The binding cleft in TRAF3 has structurally adaptive "hot spots" that can recognize motifs that are divergent from the consensus TIM [36]. Interestingly, Triad3A interaction with TRAF3 was impaired by mutation of residues within the binding crevice (Y440A/Q442A) (Figure 6B). Furthermore, Triad3A disrupts the interaction between MAVS and TRAF3 (Figure 7A), thus highlighting the importance of the TIM domain of Triad3A in regulating TRAF3 interactions by competitive binding.
###end p 49
###begin p 50
###xml 118 123 118 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#954;</italic>
###xml 166 171 162 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#954;</italic>
###xml 193 197 185 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000650-Liao1">[48]</xref>
###xml 198 202 190 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000650-Hauer1">[49]</xref>
###xml 261 265 253 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IFNB</italic>
###xml 267 272 259 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IFNA4</italic>
###xml 281 286 273 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#954;</italic>
###xml 422 427 410 411 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#954;</italic>
###xml 770 774 746 750 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000650-Fearns1">[41]</xref>
###xml 1097 1102 1073 1074 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#954;</italic>
###xml 1104 1108 1076 1080 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000650-Michallet1">[50]</xref>
###xml 1151 1156 1123 1124 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#954;</italic>
###xml 1229 1233 1197 1201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000650-Fearns1">[41]</xref>
In contrast to its positive role in the production of type I IFN, TRAF3 negatively regulates noncanonical p100/p52 NF-kappaB activation through degradation of the NF-kappaB inducing kinase NIK [48],[49]. In the present study, co-expression of Triad3A decreased IFNB, IFNA4, and NF-kappaB promoter activity by targeting TRAF3 for degradation. Although it was expected that Triad3A driven TRAF3 degradation would enhance NF-kappaB promoter activity, the observed decrease in NF-kappaB activity suggests that Triad3A may disrupt other TRAF family members such as TRAF2 and TRAF6, prevent their association with MAVS, and thus disrupt NF-kappaB activation. However, it has been previously demonstrated that Triad3A does not target TRAF2 or TRAF6 for proteasomal degradation [41]. It is also possible that some components of the p100/p52 pathway may be engaged downstream of RIG-I; this idea is strengthened by the recent report that TNFR1-associated death domain protein (TRADD) is essential for RIG-I/MAVS signaling, forms a complex with TRAF3/TANK/FADD/RIP1, and leads to activation of IRF-3 and NF-kappaB [50]. Furthermore, the effect of Triad3A on NF-kappaB activation was shown to be independent of RIP1 proteolytic degradation [41], thus strengthening the possibility that another TRAF family member associates with the TIM domain of Triad3A.
###end p 50
###begin p 51
###xml 122 124 122 124 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">63</sup>
###xml 230 234 224 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000650-Kayagaki1">[28]</xref>
###xml 432 434 426 428 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">63</sup>
###xml 564 566 552 554 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">63</sup>
###xml 646 650 628 632 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000650-Kayagaki1">[28]</xref>
###xml 689 691 671 673 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">48</sup>
###xml 766 774 748 756 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000650-g008">Figure 8</xref>
###xml 1302 1304 1280 1282 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">48</sup>
Previous studies demonstrated that TRAF3 signaling was tightly regulated by the de-ubiquitinase A (DUBA) which removed Lys63 linked Ub residues from TRAF3 and disrupted recruitment of TBK1/IKKepsilon and downstream IFN activation [28]. Dual regulation of TRAF3 by DUBA and Triad3A represents a pivotal point in the control of RLR signaling. The present results suggest a biphasic regulation or "immune-editing", whereby TRAF3 is Lys63 polyubiquitinated early after virus infection to bridge protein-protein interactions between MAVS and TBK1/IKKepsilon. Later, Lys63 polyubiquitin is removed by DUBA to disrupt TRAF3-TBK1/IKKepsilon interactions [28]; TRAF3 then undergoes a late phase Lys48-linked polyubiquitination by Triad3A, leading to proteasomal degradation (Figure 8). Such a multi-level regulation of TRAF3 underscores its key role in modulating positive and negative antiviral signaling. Furthermore, the complementary functions of DUBA and Triad3A with respect to inhibition of TRAF3 activity and turnover may be subject to stimuli- and tissue-specific regulation, a topic that warrants further investigation. In conclusion, Triad3A acts as a multi-targeting E3 ubiquitin ligase that negatively regulates the TLR, TNF-alpha and RLR pathways; in the RLR pathway, Triad3A targets TRAF3 for Lys48-linked polyubiquitination, leading to proteasome-dependent degradation, as part of the host-specific mechanism that limits the antiviral response.
###end p 51
###begin title 52
Materials and Methods
###end title 52
###begin title 53
Plasmid constructions and mutagenesis
###end title 53
###begin p 54
###xml 54 64 44 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NF-&#954;B/</italic>
###xml 70 74 56 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IFNB</italic>
###xml 81 86 67 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IFNA4</italic>
###xml 93 97 79 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ISRE</italic>
###xml 148 152 134 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000650-Kawai1">[14]</xref>
###xml 153 157 139 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000650-Lin2">[24]</xref>
###xml 158 162 144 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000650-Sharma1">[51]</xref>
###xml 163 167 149 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000650-Lin3">[52]</xref>
###xml 1025 1051 1011 1037 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GAGCAGGAGTTCTATGAGCA-3&#8242;</named-content>
###xml 1104 1130 1090 1116 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GGACACTATGCAATCACCCG-3&#8242;</named-content>
###xml 1180 1184 1166 1170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000650-Chuang1">[40]</xref>
###xml 670 675 <span type="species:ncbi:9606">Human</span>
###xml 1186 1191 <span type="species:ncbi:9606">Human</span>
###xml 1497 1509 <span type="species:ncbi:11191">Sendai virus</span>
Plasmids encoding DeltaRIG-I, MAVS, IKKepsilon, TBK1, NF-kappaB/pGL3, IFNB/pGL3, IFNA4/pGL3, ISRE-luc reporter, and pRLTK were described previously [14],[24],[51],[52]. HA-ubiquitin and other HA-Ubiquitin constructs (HA-Ub-K48, HA-Ub-K63, HA-Ub-K48R, HA-Ub-K63R, and HA-Ub-KO) were kind gifts from Dr. Zhijian Chen (Department of Molecular Biology, University of Texas Southwestern Medical Center, Dallas Texas). MDA5 and CD4-TLR3 were kind gifts from Dr. Stephen Goodbourn (Division of Basic Medical Sciences, St George's, University of London, England) and Dr. Luke A. J. O'Neill (School of Biochemistry and Immunology, Trinity College, Dublin, Ireland) respectively. Human Triad3A cDNA was amplified from pKR5 Flag-Triad3A expression plasmid and cloned into Flag and myc pcDNA3.1/Zeo. The Triad3A point mutant S320D was introduced by Quickchange Kit according to the manufacturer's instructions (Stratagene). DNA sequencing was performed to confirm the mutation. Triad3A shRNA1 targeting nucleotide sequence (1,532-1,551) 5'-GAGCAGGAGTTCTATGAGCA-3', shRNA2 targeting nucleotide sequence (1,195-1,214) 5'-GGACACTATGCAATCACCCG-3' and shRNA control have been previously described [40]. Human TRAF3 cDNA was amplified from pKR5 Flag-TRAF3 and pKR5 Flag-TRAF3 Y440A/Q442A expression plasmids provided by Dr. Genhong Cheng (UCLA, USA) and were cloned into Flag pcDNA3.1/Zeo. Mg132, lactacystin and E64 were purchased from Calbiochem. dsRNA was purchased from Invivogen. A549 cells were infected with Sendai virus (40 HAU/ml) for 16h and were treated with either Mg132 (10microM), lactacystin (5microM) or E64 (5microM) 6h p.i.
###end p 54
###begin title 55
Cell culture, transfections, and luciferase assays
###end title 55
###begin p 56
###xml 253 260 253 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Renilla</italic>
###xml 630 634 620 624 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IFNB</italic>
###xml 641 645 631 635 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ISRE</italic>
###xml 651 660 641 646 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NF-&#954;B</italic>
###xml 671 676 657 662 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IFNA4</italic>
###xml 753 757 739 743 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000650-Lin4">[53]</xref>
###xml 151 157 <span type="species:ncbi:9913">bovine</span>
###xml 957 969 <span type="species:ncbi:11191">Sendai virus</span>
###xml 1035 1040 <span type="species:ncbi:9606">Human</span>
###xml 1123 1129 <span type="species:ncbi:9913">bovine</span>
###xml 1248 1251 <span type="species:ncbi:11276">VSV</span>
###xml 1306 1318 <span type="species:ncbi:11191">Sendai virus</span>
Transfections for Luciferase assay were carried out in 293T cells grown in Dulbecco's modified Eagle's medium (Invitrogen) supplemented with 10% fetal bovine serum and antibiotics. Subconfluent 293T cells were transfected with 100 ng of pRLTK reporter (Renilla luciferase for internal control), 200 ng of pGL-3 reporter (firefly luciferase, experimental reporter), 200 ng of DeltaRIG-I, MDA5, CD4-TLR3, MAVS, TRIF, IKKepsilon, or TBK1 expression plasmids, 200 ng of pcDNA3 or Flag Triad3A/Flag Triad3A S320D pcDNA3, and 100ng of IRF-7 plasmid as indicated by calcium phosphate co-precipitation method. The reporter plasmids were: IFNB pGL3, ISRE-luc, NF-kappaB pGL3, and IFNA4 pGL-3 reporter genes; the transfection procedures were previously described [53]. At 24h after transfection, the reporter gene activities were measured by Dual-Luciferase Reporter Assay, according to manufacturer's instructions (Promega). Where indicated, cells were treated with Sendai virus (40 HAU/ml) for the indicated time or 16h for luciferase assays. Human A549 cells were cultured in F12K medium (Wisent Inc.) supplemented with 10% fetal bovine serum, glutamine and antibiotics. A549 cells were transfected either with dsRNA (20microg/ml) for 6h or infected with VSV-AV1 (multiplicity of infection of 1 (MOI)) for 16h or Sendai virus (40 HAU/ml) for 16h.
###end p 56
###begin title 57
Generation of Triad3A knock-down cells
###end title 57
###begin p 58
###xml 272 276 <span type="species:ncbi:9913">calf</span>
shRNA1 Triad3A and shRNA Control were transfected into A549 cells by using the Fugene 6 transfection reagent (Roche Applied Sciences). Cells were selected beginning at 48h post-transfection for 3 weeks in Dulbecco's modified Eagle's medium containing 10% heat-inactivated calf serum, glutamine, antibiotics, and 2 microg/ml G418 (Invitrogen); individual clones were screened for maximal knockdown of Triad3A by immunoblot.
###end p 58
###begin title 59
In vivo ubiquitination assay
###end title 59
###begin p 60
###xml 458 459 443 444 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 461 462 446 447 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 2133 2135 2078 2080 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">48</sup>
###xml 2143 2145 2088 2090 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">63</sup>
###xml 1369 1381 <span type="species:ncbi:11191">Sendai virus</span>
293T cells were transiently transfected with 2.5 microg Flag-TRAF3, 250 ng myc-Triad3A, 250 ng myc-Triad3A S320D and 1 microg HA-Ubiquitin expression plasmids. At 6h post-transfection, cells were treated with 10 microM of Mg132 where indicated. Samples were harvested 24h post-transfection, lysed using a 1% NP-40 lysis buffer (50 mM Tris-HCL ph 7.5, 150 mM NaCl, 5mM EDTA, 50 mM NaF, 1% NP-40, 10% glycerol, 30 mMbeta-glycerophosphate, 1mM orthovanadate (Na3VO4), 1 mM phenyl-methyl-sulfonyl fluoride (PMSF)) supplemented with 0.1% protease inhibitor cocktail (Sigma-Aldrich, Oakville, Ont.) and the deubiquitinase inhibitor N-ethylmaleimide (NEM, 10 mM, Sigma-Aldrich, Oakville, Ont). Samples were boiled for 10 minutes in 1% SDS and diluted 10 times in lysis buffer. 250 microg of proteins were then immunoprecipitated overnight at 4degreesC with constant agitation with 0.5 microg of anti-Flag (M2; Sigma-Aldrich) crosslinked to 30 microl of protein A/G PLUS-Agarose (Santa Cruz Biotechnology). Immunoprecipitated protein was washed 4 times with supplemented lysis buffer, denatured in 2% SDS-loading dye, and loaded onto a 7.5% acrylamide gel for SDS-PAGE analysis followed by transfer to nitrocellulose membrane. Polyubiquitination was detected by immunoblotting with a monoclonal anti-HA antibody (Sigma-Aldrich, Oakville, Canada). A549 cells were infected with Sendai virus (40 HAU/ml) in the presence of 5 microM of lactacystin and samples were collected every 4h p.i. Samples were lysed as previously described and samples were boiled for 10 minutes in 1% SDS and diluted 10 times in lysis buffer. 500 microg of proteins were then immunoprecipitated overnight at 4degreesC with constant agitation with 0.5 microg of anti-TRAF3 (sc-6933 Santa Cruz, USA) crosslinked to 30 microl of protein A/G PLUS-Agarose (Santa Cruz Biotechnology). Immunoprecipitated protein was washed 4 times with supplemented lysis buffer, denatured in 2% SDS-loading dye, and loaded onto a 7.5% acrylamide gel for SDS-PAGE analysis followed by transfer to nitrocellulose membrane. Polyubiquitination was detected by immunoblotting with polyclonal Lys48 and Lys63 anti-ubiquitin specific antibodies (Millipore, USA).
###end p 60
###begin title 61
Co-immunoprecipitation
###end title 61
###begin p 62
Cells were lysed in lysis buffer (50 mM Tris-HCl, pH 7.5, 250 mM NaCl, 0.5% NP-40) supplemented with 0.1% protease inhibitor cocktail (Sigma-Aldrich, Oakville, Canada). 250 microg of proteins were then immunoprecipitated overnight at 4degreesC with constant agitation with either 0.5 microg of anti-myc (9E10; Sigma-Aldrich) or 0.5 microg of anti-Flag (M2; Sigma-Aldrich) or 0.5 ug of anti-TRAF3 crosslinked to 30 microl of protein A/G PLUS-Agarose (Santa Cruz Biotechnology). After extensive washing with lysis buffer, the immunocomplexes were analyzed by immunoblotting as described.
###end p 62
###begin title 63
Immunoblot analysis
###end title 63
###begin p 64
###xml 653 657 639 643 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000650-Kawai1">[14]</xref>
###xml 905 909 888 892 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000650-Kawai1">[14]</xref>
###xml 1186 1190 1165 1169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000650-Servant1">[54]</xref>
###xml 1200 1202 1179 1181 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">48</sup>
###xml 1210 1212 1189 1191 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">63</sup>
###xml 862 868 <span type="species:ncbi:9986">rabbit</span>
###xml 917 920 <span type="species:ncbi:11276">VSV</span>
###xml 930 936 <span type="species:ncbi:9986">rabbit</span>
###xml 966 969 <span type="species:ncbi:11276">VSV</span>
###xml 1141 1147 <span type="species:ncbi:9986">rabbit</span>
Whole cell extracts (20-40 microg) were separated in 7.5-12% acrylamide gel by SDS-PAGE and were transferred to a nitrocellulose membrane (BioRad, Mississauga, Canada) at 4degreesC for 1h at 100 V in a buffer containing 30 mM Tris, 200 mM glycine and 20% (vol/vol) methanol. Membranes were blocked for 1h at room temperature in 5% (vol/vol) dried milk in PBS and 0.1% (vol/vol) Tween-20 and then were probed with primary antibodies. Anti-Flag (M2), anti-Hemagglutinin HA (H7), or anti-myc (9E10) each at a concentration of 1 microg/ml were purchased from Sigma-Aldrich (Sigma-Aldrich, Oakville, Canada); anti-MAVS (1:1000, in-house previously described [14]) were prepared in blocking solution plus 0.02% sodium azide. Anti-IRF-3 (1:5000, IBL, Japan), anti-beta-Actin (1:5000, MAB1501 Millipore, USA), anti-Triad3A (1:1000, ProSci Inc. USA), anti-RIG-I (1:1000, rabbit polyclonal Ab, previously described [14]), anti-VSV (1:3000, rabbit polyclonal Ab raised against VSV proteins G, N, and M), anti-ISG56 (1:1000, gift from Dr. Ganes Sen, Cleveland Clinic), anti-TRAF3 (1 microg/ml, sc-6933 Santa Cruz, Cal, USA), anti-IRF-3 Ser 396 (1:1000, rabbit anti-peptide Ab, previously described [54]), and Lys48 and Lys63 anti-ubiquitin specific antibody (1:1000, Millipore, USA) were prepared in 3% BSA/PBS/0.03% sodium azide.
###end p 64
###begin title 65
IRF-3 dimerization
###end title 65
###begin p 66
###xml 142 143 142 143 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 145 146 145 146 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 1275 1286 <span type="species:ncbi:3704">horseradish</span>
###xml 1309 1313 <span type="species:ncbi:9925">goat</span>
###xml 1319 1325 <span type="species:ncbi:9986">rabbit</span>
Whole cell extracts were prepared in Nonidet P-40 lysis buffer (50 mM Tris, pH 7.4, 150 mM NaCl, 30 mM NaF, 5 mM EDTA, 10% glycerol, 1.0 mM Na3VO4, 40 mM beta-glycerophosphate, 0.1 mM phenylmethylsulfonyl fluoride, 5 microg/ml of each leupeptin, pepstatin, and aprotinin, and 1% Nonidet P-40), and then were subjected to electrophoresis on 7.5% native acrylamide gels, which were pre-run for 30 min at 4degreesC. The electrophoresis buffers were composed of an upper chamber buffer (25 mM Tris, pH 8.4, 192 mM glycine, and 1% sodium deoxycholate) and a lower chamber buffer (25 mM Tris, pH 8.4, 192 mM glycine). Gels were soaked in SDS running buffer (25 mM Tris, pH 8.4, 250 mM glycine, 0.1% SDS) for 30 min at 25degreesC and were then electrophoretically transferred on Hybond-C nitrocellulose membranes (Amersham Biosciences) in 25 mM Tris, pH 8.4, 192 mM glycine, and 20% methanol for 1 h at 4degreesC. Membranes were blocked in phosphate-buffered saline containing 5% (vol/vol) nonfat dry milk and 0.05% (vol/vol) Tween 20 for 1 h at 25degreesC and then were blotted with an antibody against IRF-3 (1 microg/ml) in blocking solution for 1 h at 25degreesC. After washing the membranes five times in phosphate-buffered saline/0.05% Tween, they were incubated for 1 h with horseradish peroxidase-conjugated goat anti-rabbit IgG (1:4000) in blocking solution. Immunoreactive bands were visualized by enhanced chemiluminescence (Amersham Biosciences).
###end p 66
###begin title 67
Real-time PCR
###end title 67
###begin p 68
###xml 148 154 148 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IFN-&#223;</italic>
###xml 156 182 155 181 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TTGTGCTTCTCCACTACAGC-3&#8242;</named-content>
###xml 197 223 196 222 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CTGTAAGTCTGTTAATGAAG-3&#8242;</named-content>
###xml 235 245 234 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IFN-&#945;2</italic>
###xml 247 275 242 270 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CCTGATGAAGGAGGACTCCATT-3&#8242;</named-content>
###xml 290 317 285 312 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-AAAAAGGTGAGCTGGCATACG-3&#8242;</named-content>
###xml 329 334 324 329 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ISG15</italic>
###xml 336 361 331 356 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-AGCTCCATGTCGGTGTCAG-3&#8242;</named-content>
###xml 376 402 371 397 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GAAGGTCAGCCAGAACAGGT-3&#8242;</named-content>
###xml 414 419 409 414 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ISG56</italic>
###xml 419 445 414 440 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CAACCAAGCAAATGTGAGGA-3&#8242;</named-content>
###xml 460 486 455 481 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-AGGGGAAGCAAAGAAAATGG-3&#8242;</named-content>
###xml 498 504 493 499 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CXCL10</italic>
###xml 504 531 499 526 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TTCCTGCAAGCCAATTTTGTC-3&#8242;</named-content>
###xml 546 577 541 572 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TCTTCTCACCCTTCTTTTTCATTGT-3&#8242;</named-content>
###xml 589 594 584 589 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1</italic>
###xml 594 618 589 613 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CCTGCTGCGGTTCAGTGA-3&#8242;</named-content>
###xml 633 660 628 655 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TCCACCCATGTGAATGTGATG-3&#8242;</named-content>
###xml 672 680 667 674 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#223;-Actin</italic>
###xml 682 709 676 703 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CCTTCCTGGGCATGGAGTCCT-3&#8242;</named-content>
###xml 724 751 718 745 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-AATCTCATCTTGTTTTCTGCG-3&#8242;</named-content>
###xml 898 906 892 899 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#223;-Actin</italic>
###xml 1241 1242 1234 1235 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 1242 1243 1235 1236 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</sub>
###xml 1094 1106 <span type="species:ncbi:11191">Sendai virus</span>
Quantitative PCR assays were performed in triplicate using the AB 7500 Real-time PCR System (Applied Biosystems). The primers used were as follows: IFN-ss, 5'-TTGTGCTTCTCCACTACAGC-3' (forward) and 5'-CTGTAAGTCTGTTAATGAAG-3' (reverse); IFN-alpha2, 5'-CCTGATGAAGGAGGACTCCATT-3' (forward) and 5'-AAAAAGGTGAGCTGGCATACG-3' (reverse); ISG15, 5'-AGCTCCATGTCGGTGTCAG-3' (forward) and 5'-GAAGGTCAGCCAGAACAGGT-3' (reverse); ISG565'-CAACCAAGCAAATGTGAGGA-3' (forward) and 5'-AGGGGAAGCAAAGAAAATGG-3' (reverse); CXCL105'-TTCCTGCAAGCCAATTTTGTC-3' (forward) and 5'-TCTTCTCACCCTTCTTTTTCATTGT-3' (reverse); STAT15'-CCTGCTGCGGTTCAGTGA-3' (forward) and 5'-TCCACCCATGTGAATGTGATG-3' (reverse); ss-Actin, 5'-CCTTCCTGGGCATGGAGTCCT-3' (forward) and 5'-AATCTCATCTTGTTTTCTGCG-3' (reverse). All data are presented as a relative quantification with efficiency correction based on the relative expression of target genes versus ss-Actin as reference gene. Standard curves and PCR efficiencies were obtained using serial dilutions of pooled cDNA prepared from stable shRNA1 Triad3A and shRNA control A549 cells infected with Sendai virus (40 HAU/ml) for 12h. Data were then collected using the AB 7500 Real-time PCR System (Applied Biosystems) and analyzed by comparative CT method using the SDS version 1.3.1 Relative Quantification software.
###end p 68
###begin title 69
ELISA
###end title 69
###begin p 70
###xml 81 93 <span type="species:ncbi:11191">Sendai virus</span>
The supernatants from stable shRNA Triad3A and shRNA Control cells infected with Sendai virus (40 HAU/ml) were collected at 12h p.i. The concentrations of IFN-beta and IFN-alpha in the supernatants were measured using ELISA kits (PBL Biomedical Laboratories, Piscataway, NJ).
###end p 70
###begin title 71
Supporting Information
###end title 71
###begin p 72
###xml 131 135 131 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ISRE</italic>
Triad3A blocks RIG-I/MAVS and TRIF-mediated ISRE transactivation. 293T cells were transfected with pRLTK control plasmid (100 ng), ISRE-Luc reporter plasmid (200 ng), RIG-I (A)-, MAVS (B)-, TRIF (C)-, or TBK1(D)-expressing plasmid (200 ng) together with an increase amount of Triad3A expression plasmid (0, 50, 200, and 1000 ng) as indicated. In all transfections, the pcDNA3 vector was added to bring the total plasmids to 1500 ng. Luciferase activity was analyzed at 24h post-transfection by the Dual-Luciferase Reporter assay as described by the manufacturer (Promega). Relative luciferase activity was measured as fold activation (relative to the basal level of reporter gene in the presence of pcDNA3 vector after normalization with co-transfected RLU activity); values are mean +/- S.D. for three experiments.
###end p 72
###begin p 73
(0.37 MB TIF)
###end p 73
###begin p 74
Click here for additional data file.
###end p 74
###begin p 75
###xml 111 115 111 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IFNB</italic>
###xml 126 135 126 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NF-&#954;B</italic>
Triad3A inhibits MDA5 and CD4-TLR3 transactivation. 293T cells were transfected with pRLTK control plasmid and IFNB-pGL3 (A), NF-kappaB (B) reporter plasmid and the pcDNA3 vector or expression plasmids encoding MDA5 and CD4-TLR3, as well as Triad3A expression plasmid as indicated. Luciferase activity was analyzed at 24h post-transfection by the Dual-Luciferase Reporter assay as described by the manufacturer (Promega). Relative luciferase activity was measured as fold activation (relative to the basal level of reporter gene in the presence of pcDNA3 vector after normalization with co-transfected RLU activity); values are mean +/- S.D. for three experiments.
###end p 75
###begin p 76
(0.44 MB TIF)
###end p 76
###begin p 77
Click here for additional data file.
###end p 77
###begin p 78
###xml 208 211 <span type="species:ncbi:11191">SeV</span>
dsRNA treatment promotes TRAF3 degradation. A549 cells were treated with dsRNA 20microg/ml and cells were collected every 2h post-treatment. Cell lysates were analyzed by immunoblotting with anti-TRAF3, anti-SeV, and anti-ISG56 antibodies.
###end p 78
###begin p 79
(0.25 MB TIF)
###end p 79
###begin p 80
Click here for additional data file.
###end p 80
###begin p 81
Triad3A S320D does not alter TRAF3 protein expression. 293T cells were co-transfected with expression vectors for Flag-tagged TRAF3 and increasing amount of expression vector for myc-tagged Triad3A S320D as indicated. The cells were subsequently lysed, and cell lysates were resolved by SDS-PAGE. The expression levels of TRAF3, Triad3A S320D, and beta-actin were analyzed by immunoblotting with antibodies against myc, Flag, or beta-Actin, respectively.
###end p 81
###begin p 82
(0.39 MB TIF)
###end p 82
###begin p 83
Click here for additional data file.
###end p 83
###begin p 84
We thank Drs. Zhijian J. Chen and Genhong Cheng and for reagents used in this study, as well as the members of the Molecular Oncology Group, Lady Davis Institute, Dr. Nathalie Grandvaux (University of Montreal) and Dr. Meztli Arguello for helpful discussions, and Peter Wilkinson (CR-CHUM) for his help in bioinformatics.
###end p 84
###begin title 85
References
###end title 85
###begin article-title 86
RIG-I-like receptors: Sensing and responding to RNA virus infection.
###end article-title 86
###begin article-title 87
TLRs, NLRs and RLRs: a trinity of pathogen sensors that co-operate in innate immunity.
###end article-title 87
###begin article-title 88
Pathogen recognition and innate immunity.
###end article-title 88
###begin article-title 89
MasterCARD: a priceless link to innate immunity.
###end article-title 89
###begin article-title 90
The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses.
###end article-title 90
###begin article-title 91
Shared and unique functions of the DExD/H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity.
###end article-title 91
###begin article-title 92
The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-beta promoter.
###end article-title 92
###begin article-title 93
The C-terminal regulatory domain is the RNA 5'-triphosphate sensor of RIG-I.
###end article-title 93
###begin article-title 94
Nonself RNA-sensing mechanism of RIG-I helicase and activation of antiviral immune responses.
###end article-title 94
###begin article-title 95
5'-Triphosphate RNA is the ligand for RIG-I.
###end article-title 95
###begin article-title 96
Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3.
###end article-title 96
###begin article-title 97
###xml 79 96 <span type="species:ncbi:11103">hepatitis C virus</span>
Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus.
###end article-title 97
###begin article-title 98
VISA Is an Adapter Protein Required for Virus-Triggered IFN-beta Signaling.
###end article-title 98
###begin article-title 99
IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction.
###end article-title 99
###begin article-title 100
###xml 111 128 <span type="species:ncbi:11103">hepatitis C virus</span>
Dissociation of a MAVS/IPS-1/VISA/Cardif-IKKepsilon molecular complex from the mitochondrial outer membrane by hepatitis C virus NS3-4A proteolytic cleavage.
###end article-title 100
###begin article-title 101
CARD games between virus and host get a new player.
###end article-title 101
###begin article-title 102
Toll-like receptors, RIG-I-like RNA helicases and the antiviral innate immune response.
###end article-title 102
###begin article-title 103
Toll-like receptors and RNA helicases: two parallel ways to trigger antiviral responses.
###end article-title 103
###begin article-title 104
Convergence of the NF-kappaB and IRF pathways in the regulation of the innate antiviral response.
###end article-title 104
###begin article-title 105
Negative receptor signalling.
###end article-title 105
###begin article-title 106
The age of crosstalk: phosphorylation, ubiquitination, and beyond.
###end article-title 106
###begin article-title 107
Ubiquitination and TRAF signaling.
###end article-title 107
###begin article-title 108
Ubiquitin signalling in the NF-kappaB pathway.
###end article-title 108
###begin article-title 109
Negative regulation of the retinoic acid-inducible gene I-induced antiviral state by the ubiquitin-editing protein A20.
###end article-title 109
###begin article-title 110
A20 is a negative regulator of IFN regulatory factor 3 signaling.
###end article-title 110
###begin article-title 111
###xml 39 51 <span type="species:ncbi:11191">Sendai virus</span>
A20 is a potent inhibitor of TLR3- and Sendai virus-induced activation of NF-kappaB and ISRE and IFN-beta promoter.
###end article-title 111
###begin article-title 112
Regulation of IKK-related kinases and antiviral responses by tumor suppressor CYLD.
###end article-title 112
###begin article-title 113
DUBA: a deubiquitinase that regulates type I interferon production.
###end article-title 113
###begin article-title 114
###xml 81 98 <span type="species:ncbi:11103">hepatitis C virus</span>
MAVS dimer is a crucial signaling component of innate immunity and the target of hepatitis C virus NS3/4A protease.
###end article-title 114
###begin article-title 115
Mavs Self-Association Mediates Antiviral Innate Immune Signaling.
###end article-title 115
###begin article-title 116
Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6.
###end article-title 116
###begin article-title 117
Critical role of TRAF3 in the Toll-like receptor-dependent and -independent antiviral response.
###end article-title 117
###begin article-title 118
Tumor necrosis factor receptor-associated factor 2 (TRAF2)-deficient B lymphocytes reveal novel roles for TRAF2 in CD40 signaling.
###end article-title 118
###begin article-title 119
Key molecular contacts promote recognition of the BAFF receptor by TNF receptor-associated factor 3: implications for intracellular signaling regulation.
###end article-title 119
###begin article-title 120
Molecular basis for CD40 signaling mediated by TRAF3.
###end article-title 120
###begin article-title 121
Structurally distinct recognition motifs in lymphotoxin-beta receptor and CD40 for tumor necrosis factor receptor-associated factor (TRAF)-mediated signaling.
###end article-title 121
###begin article-title 122
Downstream regulator TANK binds to the CD40 recognition site on TRAF3.
###end article-title 122
###begin article-title 123
###xml 22 40 <span type="species:ncbi:10376">Epstein-Barr virus</span>
LMP1 protein from the Epstein-Barr virus is a structural CD40 decoy in B lymphocytes for binding to TRAF3.
###end article-title 123
###begin article-title 124
Regulation of antiviral responses by a direct and specific interaction between TRAF3 and Cardif.
###end article-title 124
###begin article-title 125
Triad3A, an E3 ubiquitin-protein ligase regulating Toll-like receptors.
###end article-title 125
###begin article-title 126
Triad3A regulates ubiquitination and proteasomal degradation of RIP1 following disruption of Hsp90 binding.
###end article-title 126
###begin article-title 127
Induction of IRF-3 and IRF-7 phosphorylation following activation of the RIG-I pathway.
###end article-title 127
###begin article-title 128
Negative regulation of the RIG-I signaling by the ubiquitin ligase RNF125.
###end article-title 128
###begin article-title 129
Ubiquitin chain editing revealed by polyubiquitin linkage-specific antibodies.
###end article-title 129
###begin article-title 130
TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity.
###end article-title 130
###begin article-title 131
Involvement of CRAF1, a relative of TRAF, in CD40 signaling.
###end article-title 131
###begin article-title 132
A novel RING finger protein interacts with the cytoplasmic domain of CD40.
###end article-title 132
###begin article-title 133
Regulation of the NF-kappaB-inducing kinase by tumor necrosis factor receptor-associated factor 3-induced degradation.
###end article-title 133
###begin article-title 134
TNF receptor (TNFR)-associated factor (TRAF) 3 serves as an inhibitor of TRAF2/5-mediated activation of the noncanonical NF-kappaB pathway by TRAF-binding TNFRs.
###end article-title 134
###begin article-title 135
TRADD protein is an essential component of the RIG-like helicase antiviral pathway.
###end article-title 135
###begin article-title 136
Triggering the interferon antiviral response through an IKK-related pathway.
###end article-title 136
###begin article-title 137
Multiple regulatory domains control IRF-7 activity in response to virus infection.
###end article-title 137
###begin article-title 138
Selective DNA binding and association with the CREB binding protein coactivator contribute to differential activation of alpha/beta interferon genes by interferon regulatory factors 3 and 7.
###end article-title 138
###begin article-title 139
Identification of Distinct Signaling Pathways Leading to the Phosphorylation of Interferon Regulatory Factor 3.
###end article-title 139
###begin p 140
The authors have declared that no competing interests exist.
###end p 140
###begin p 141
This research was supported by grants from the Canadian Institutes of Health Research (JH and RL), CANFAR (JH) and the Canadian Cancer Society (JH). PN and MS were supported by FRSQ Doctoral Award, and CIHR CGS Doctoral Award, respectively. RL was supported by a FRSQ Chercheur-boursier and JH by a CHIR Senior Investigator Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 141

